ESTROPIPATE Drug Patent Profile
✉ Email this page to a colleague
When do Estropipate patents expire, and when can generic versions of Estropipate launch?
Estropipate is a drug marketed by Barr, Duramed Pharms Barr, Mylan, Watson Labs, and Watson Labs Teva. and is included in seven NDAs.
The generic ingredient in ESTROPIPATE is estropipate. There are two drug master file entries for this compound. Additional details are available on the estropipate profile page.
Summary for ESTROPIPATE
| US Patents: | 0 |
| Applicants: | 5 |
| NDAs: | 7 |
| Raw Ingredient (Bulk) Api Vendors: | 62 |
| Patent Applications: | 2,933 |
| Formulation / Manufacturing: | see details |
| Drug Prices: | Drug price information for ESTROPIPATE |
| DailyMed Link: | ESTROPIPATE at DailyMed |
US Patents and Regulatory Information for ESTROPIPATE
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Barr | ESTROPIPATE | estropipate | TABLET;ORAL | 040135-001 | Nov 27, 1996 | DISCN | No | No | ⤷ Try a Trial | ⤷ Try a Trial | ⤷ Try a Trial | ||||
| Mylan | ESTROPIPATE | estropipate | TABLET;ORAL | 040359-001 | Aug 26, 1999 | DISCN | No | No | ⤷ Try a Trial | ⤷ Try a Trial | ⤷ Try a Trial | ||||
| Duramed Pharms Barr | ESTROPIPATE | estropipate | TABLET;ORAL | 040296-001 | Nov 1, 1999 | DISCN | No | No | ⤷ Try a Trial | ⤷ Try a Trial | ⤷ Try a Trial | ||||
| Watson Labs | ESTROPIPATE | estropipate | TABLET;ORAL | 081216-001 | Sep 23, 1993 | DISCN | No | No | ⤷ Try a Trial | ⤷ Try a Trial | ⤷ Try a Trial | ||||
| Mylan | ESTROPIPATE | estropipate | TABLET;ORAL | 040359-002 | Aug 26, 1999 | DISCN | No | No | ⤷ Try a Trial | ⤷ Try a Trial | ⤷ Try a Trial | ||||
| Barr | ESTROPIPATE | estropipate | TABLET;ORAL | 040135-002 | Nov 27, 1996 | DISCN | No | No | ⤷ Try a Trial | ⤷ Try a Trial | ⤷ Try a Trial | ||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
